Golden
Charter Life Sciences

Charter Life Sciences

Charter Life Sciences is a Mountain View based venture capital firm focused on clinical stage investments in early-stage opportunities.

Charter Life Sciences is a Mountain View, California based venture capital firm. They focus on clinical-stage investments in early-stage opportunities.



Their preferred investments are in biotechnology and drug development companies, especially in biologic and small molecule opportunities; medical device companies, especially therapeutic devices and diagnostic opportunities; and health care information technology companies, especially in companies focused on information access needs but not in consumer focused healthcare information technology. 



Charter Life Sciences will invest in Series A or Series B rounds, with some later round financing, and their initial investment ranges from $1 million to $5 million and want board representation as a condition of investment.



Investment

Charter Life Sciences has made investments in WhiteLight Systems, KFx Medical, Kereos, Bullhorn, Amaranth Medical, CoMentis, Mirabilis Medica, APT Pharmaceutical, Prevacept Infection Control and Minimally invasive devices.



They exited their investment in CymaBay Therapeutics, Bullhorn, Xlumena, Inviragen and WhiteLight Systems.

Timeline

People

Name
Role
LinkedIn

A. Barr Dolan

Managing Partner



Andrew K. Klatt

Partner, Chief Financial Officer



Donald C. Harrison, M.D.

Managing Partner



Gino Di Sciullo, Ph.D.

Partner



James H. Liu, MD

Advisor



Jerrold M. Olefsky, MD

Advisor



Nelson Teng, M.D.

Managing Partner



Stanley N. Cohen, MD

Advisor



Stuart B. Goodman, MD, PhD

Advisor



Yuet W. Kan, MD

Advisor



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References